Research On Safety Supervision Mode Of Drugs In China

Drug safety issues related to people’s health and safety, but also related to people’s livelihood and even social stability of the important issues, so drug safety is crucial. However, China’s government departments alone regulatory model is clearly not meet regulatory needs, leading to frequent drug safety problems, a serious impact on the credibility of government regulators. In the party’s congress report, the CPC Central Committee,"second five" plan proposed draft and the2012report of the two sessions, mentioned the need to "strengthen social management and innovation," perfect party leadership, government responsibility, social coordination, public participation social management pattern. In this context, the drug safety supervision system should adapt to the new form, give full play to the role of society and the public, allowing them to actively participate in the monitoring, to establish a pattern of multiple subjects involved. In the international arena, many developed countries in drug safety regulation, industry organizations, third-party organizations, consumer organizations, and so be able to actively participate, and the government do complement each other in ensuring drug safety play an active role, and its experience is worth our reference.Drug safety supervision of multiple subjects around this theme, first introduced the drug safety supervision relevant concepts and theoretical basis for drug safety monitoring and drug safety supervision of multiple subjects involved in the necessity of looking for a theoretical model of support and certification; followed by an analysis of the development of China’s drug safety supervision and status, while China’s drug safety supervision on the problems in-depth analysis; then passed through the part of the national drug regulatory status of the typical research and comparison, the experience is worth learning and enlightenment; final propose appropriate policy recommendations to improve the government’s regulatory regime advocated the same time, to strengthen industry associations and organizations related to the construction of consumer protection, in order to improve regulatory efficiency and level, to better ensure the quality of medicines and people drug safety.